Ustekinumab is used to treat moderate to severe plaque psoriasis in adults and children 6 years of age and older who are candidates for phototherapy
PORTLAND, OREGON, UNITED STATES, February 23, 2023 /EINPresswire.com/ —
What is Ustekinumab?
Ustekinumab is a prescription medication used to treat certain autoimmune diseases, such as psoriasis, psoriatic arthritis, and Crohn’s disease. It works by targeting and blocking the action of interleukin-12 and interleukin-23, two proteins involved in triggering inflammation.
Ustekinumab is given by injection and is typically administered every 12 weeks, although the exact dosing schedule may vary depending on the specific condition being treated and the patient’s response to the medication.
Common side effects of ustekinumab include infections, headaches, and reactions at the injection site. More serious side effects are also possible, so it is important to talk to your doctor about the potential benefits and risks of using this medication.
It’s important to note that ustekinumab is not a cure for autoimmune diseases and does not work for everyone. Your doctor can help you determine if ustekinumab is a suitable treatment option for you based on your individual health status and medical history.
Download Report Sample- https://www.alliedmarketresearch.com/request-toc-and-sample/13981
What is Ustekinumab Market?
The market for ustekinumab, a medication used to treat certain autoimmune diseases, has seen significant growth in recent years due to the increasing prevalence of these conditions. According to market research, the global ustekinumab market is expected to continue to grow at a high rate in the coming years, driven by factors such as the increasing number of people affected by autoimmune diseases and the increasing awareness of these conditions.
In addition, the growing number of approvals and launches of new biologic drugs, including ustekinumab, is also contributing to the growth of the market. The increasing investments made by pharmaceutical companies to develop new treatments for autoimmune diseases is also expected to drive the growth of the ustekinumab market in the future.
Do Inquiry before buying – https://www.alliedmarketresearch.com/purchase-enquiry/13981
However, despite the growth of the market, several factors, such as the high cost of ustekinumab and other biologic drugs, the lack of awareness about autoimmune diseases in some regions, and the availability of alternative treatments, may act as a barrier to the growth of the market.
Know More- https://www.alliedmarketresearch.com/ustekinumab-market-A13612
Related Reports –
Hysterectomy Devices Market – https://www.alliedmarketresearch.com/hysterectomy-devices-market-A13324
Health Coaching Market – https://www.alliedmarketresearch.com/health-coaching-market-A13404
Multivitamin Supplements Market – https://www.alliedmarketresearch.com/multivitamin-supplements-market-A13371
Drug Delivery Devices Market – https://www.alliedmarketresearch.com/drug-delivery-devices-market-A06095
David Correa
Allied Analytics LLP
+ +1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
